Teleflex Incorporated

NYSE:TFX  
207.56
-4.32 (-2.04%)
Debt Financing / Related, Other Pre-Announcement

Teleflex To Expand Its Surgical Portfolio With Differentiated Stapling Technology For Bariatric Surgery

Published: 08/22/2022 11:48 GMT
Teleflex Incorporated (TFX) - Teleflex to Expand Its Surgical Portfolio With Differentiated Stapling Technology for Bariatric Surgery.
Teleflex Inc - Teleflex Will Acquire Standard Bariatrics for an Upfront Cash Payment of $170 Million at Closing.
Teleflex Inc - Proposed Deal Includes Additional Consideration of Up to $130 Million Payable Upon Achievement of Certain Commercial Milestones.
Teleflex Inc - Plans to Finance Acquisition at Closing Through Borrowings Under Its Revolving Credit Facility.
Teleflex Inc - for Fiscal Year 2022, Transaction is Not Expected to Contribute Meaningfully to Teleflex Revenue.
Teleflex Inc - for Fiscal Year 2022, Transaction is Expected to Be About $0.10 Dilutive to Adjusted Earnings per Share.
Teleflex Inc - for Fiscal Year 2023, Transaction is Expected to Contribute Between $30 and $35 Million of Revenue.
Teleflex Inc - for Fiscal Year 2023, Transaction is Expected to Contribute Approximately $0.10 to $0.15 Dilutive to Adjusted Earnings per Share.
Teleflex Inc - Transaction is Expected to Be Accretive to Revenue Growth and Adjusted EPS Thereafter Fiscal Year 2022 and 2023.